Chorionic gonadotropin - Wyeth

Drug Profile

Chorionic gonadotropin - Wyeth

Alternative Names: APL; CG; Choriogonadotrophin; Gonadotrophin chorionic; Gonadotropin chorionic; Human chorionic gonadotrophin; Human chorionic gonadotropin; Pregnancy urine hormone

Latest Information Update: 25 Oct 2000

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wyeth
  • Developer Nonindustrial source; Wyeth
  • Class Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormones
  • Mechanism of Action Apoptosis stimulants; Ribonuclease stimulants; RNA inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Kaposi's sarcoma

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 25 Oct 2000 No-Development-Reported for Kaposi's sarcoma in United Kingdom (IM)
  • 25 Oct 2000 No-Development-Reported for Kaposi's sarcoma in USA (Intralesional)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top